capecitabine has been researched along with Dermatomyositis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alsarheed, A; Cobos, GA; LaChance, A; Laga, AC; LeBoeuf, N; Nelson, CA; Vleugels, RA | 1 |
| Linares-Gonzalez, L; Ródenas-Herranz, T; Ruiz-Villaverde, R; Sánchez-Cano, D | 1 |
| Chen, FW; Egbert, BM; Sarin, KY; Swetter, SM; Zhou, X | 1 |
3 other study(ies) available for capecitabine and Dermatomyositis
| Article | Year |
|---|---|
Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Dermatomyositis; Diagnosis, Differential; Female; Hand-Foot Syndrome; Humans; Middle Aged | 2020 |
Capecitabine-induced bilateral ectropion on a patient with paraneoplastic dermatomyositis.
Topics: Autoantibodies; Capecitabine; Dermatomyositis; Ectropion; Humans; Paraneoplastic Syndromes | 2020 |
Dermatomyositis associated with capecitabine in the setting of malignancy.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Biopsy, Needle; Capecitabine; Deoxycytidine; Dermatomyositis; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Male; Risk Assessment; Stomach Neoplasms | 2014 |